Project CBD

MARCH 21, 2023

All but two of the 45 respondents said they’d consider cannabis as a treatment, with 29 seeking help for sleep disturbances, 27 for emotional complaints, 25 for functional disturbances, and nine for pain. Despite all this, there is a potential biological rationale for the treatment of tinnitus with cannabinoids, the authors explain.

Cannabinoids 144

Cannabinoids Clinical Trials Sleep Blood Pressure 144

NewsMunchies

DECEMBER 13, 2021

In the largest clinical trial to date, a new study conducted by the UK-based pharmaceutical company Compass Pathways shows that psilocybin or “magic” mushrooms can safely relieve depression. The trial included 233 patients from 10 countries in North America and Europe. In 2019, Denver became the first city in the U.S.

Clinical Trials 95

Clinical Trials Therapy Decriminalization Patients 95

CannaMD

APRIL 23, 2020

For those unfamiliar, GB Sciences is a technology company that merges plant biology, cultivation, and post-production processes in order to optimize safe, consistent medical cannabis treatment. And sure enough, in early 2020, GB Sciences took another important step forward. Advancing Parkinson’s Disease & Cannabis Research.

Clinical Trials 116

Clinical Trials Research and Development Marijuana Treatment 116

Cannabis Law Report

DECEMBER 9, 2021

The Financing will allow the Company to continue progressing its R&D, clinical trials and technology initiatives. “I I’m proud of our accomplishments to date and look forward to kicking off multiple clinical trials in early 2022,” said CEO, Josh Bartch. DENVER, Dec. DENVER, Dec.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

The Cannigma

MARCH 18, 2021

Taken together, the lack of guidance and lack of information about what treatments patients are taking, may underlie “inconsistencies in both use and reported effectiveness,” the researchers stated. The study was compiled by way of an anonymous email survey sent to 7,607 people with Parkinson’s disease in January 2020.

Patients 145

Patients Clinical Trials Treatment Cannabis 145

Cannabis Law Report

AUGUST 10, 2021

This acquisition is focused on becoming the first and only company solving the puzzle of chronic pain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development. The global chronic pain treatment market is predicted to progress at a CAGR of 6.5% from 2020 to 2030 and generate revenue of $151.7

Chronic Pain 105

Chronic Pain Clinical Trials Research and Development Events 105

Cannabis Law Report

AUGUST 12, 2021

loss per share, during the same period in 2020 (after including non-cash share-based compensation expense of $11.4 Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. million during the same period in 2020.

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

The Cannigma

MAY 19, 2021

This was notoriously reflected in the 2020 arrest of a Japanese man and woman for speaking positively about using cannabis in social media posts. In 2019, Japan approved clinical trials for Epidiolox — a cannabis derived medicine used to treat severe forms of childhood epilepsy such as Dravet and Lennox-Gastaut syndromes.

Law 145

Law Legalization Clinical Trials CBD 145

CannaMD

JUNE 2, 2021

In a paper presented at the 2020 International Congress of Parkinson’s Disease and Movement Disorders , the authors reported on the results of an anonymous survey completed by more than 1,000 individuals living with Parkinson’s disease.

Patients 105

Patients Clinical Trials Treatment Research and Development 105

Puff Puff Post

MARCH 10, 2020

“We are very pleased with the rapid completion of enrollment achieved by the team at the Centre for Human Drug Research (CHDR) in Leiden, the Netherlands,” said Alexandra Mancini, InMed’s Senior Vice President of Clinical Development & Regulatory Affairs. SOURCE InMed Pharmaceuticals Inc.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Puff Puff Post

JANUARY 1, 2020

One particularly promising area of research is in the treatment of cancer. Cancer patients suffer not only from cancer, but the damaging effects of treatment. Cannabis Cancer Treatments as an Alternative to Opioids. Therefore doctors now consider cannabis as the better treatment option. In some cases opiods work better.

Treatment 49

Treatment Clinical Trials Research and Development Cannabinoids 49

Veriheal

JULY 16, 2020

Following months of meetings, the Creating Options for Veterans Expedited Recovery ( COVER ) Commission released its report in January 2020. from doing any research about the efficacy or risks of these treatment options. The supply of research-grade cannabis, together with other controlled substances, is woefully inadequate.

Research and Development 97

Research and Development Clinical Trials Treatment Compliance 97

CannaMD

SEPTEMBER 9, 2020

Published only recently, in May of 2020, this clinical trial is the first to show that microdoses of cannabis can be just as effective as much higher doses. They gave 27 patients with chronic pain (reporting pain levels of at least six out of 10) one of the following treatment options: 5mg of inhaled THC. Get Started.

Microdosing 111

Microdosing Marijuana Clinical Trials Chronic Pain 111

Veriheal

FEBRUARY 11, 2021

The objective of the survey published in December 2020 explored “ the effect that medical cannabis has on prescription opioid medication usage for the treatment of chronic pain at three medical cannabis practice sites ”. The Effect of Medical Cannabis on Prescription Opioids.

Chronic Pain 93

Chronic Pain Patients Clinical Trials Treatment 93

Cannabis Law Report

SEPTEMBER 1, 2021

Going public in November 2020 on the NEO exchange, the firm has been steadily growing its market cap and development pipeline. The company recently became the industry’s first firm to list on the NYSE American exchange and their psilocybin clinical trial for depression is making excellent progress. Field Trip Health Ltd.

Research and Development 102

Research and Development Therapy Clinical Trials Pharmaceutical 102

NewsMunchies

NOVEMBER 12, 2021

In clinical trials, psilocybin (the psychoactive substance in mushrooms) has shown tremendous promise in treating severe depression, post-traumatic stress disorder, and other mental illnesses. Additional clinical trials underway in the U.S. While the science on psychedelics is exploding, there are roadblocks in the way.

Clinical Trials 90

Clinical Trials Therapy Decriminalization DEA 90

Puff Puff Post

JANUARY 1, 2020

One particularly promising area of research is in the treatment of cancer. Cancer patients suffer not only from cancer, but the damaging effects of treatment. Cannabis Cancer Treatments as an Alternative to Opioids. Therefore doctors now consider cannabis as the better treatment option. In some cases opiods work better.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

Cannabis Law Report

JULY 9, 2021

Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. See Deborah Brauser, FDA Permits Psilocybin to Be Tested for Refractory Depression, MEDSCAPE (Oct.

Law 81

Law Therapy Clinical Trials Research and Development 81

Cannabis Law Report

OCTOBER 15, 2021

(USOTC: PAOG) cited a British Medical Journal case study report published today on the effectiveness of CBD in the treatment of lung cancer and COPD as validation of PAOG’s ongoing research and development of its own respiratory disorder treatment under the name RespRx. 9,199,960). Billion , and it is expected to reach $16.4

Treatment 52

Treatment Research and Development CBD eCommerce 52

Veriheal

JULY 24, 2023

The 2020 study enlisted 24 participants with depression, giving them varying doses of psilocybin. The study’s results blew researchers away showing that psilocybin’s effect on those with depression “…was about four times larger than what clinical trials have shown for traditional antidepressants on the market”.

Therapy 98

Therapy Clinical Trials Treatment Cannabis 98

LifeCannMD

MAY 27, 2025

Sleep: What the Sleep Studies Reveal A groundbreaking 2020 study from the University of New Mexico analyzed sleep data from over 5,000 medical marijuana patients. times more likely to achieve their treatment goals with medical cannabis. This gives us baseline measurements that we can track over time.

Microdosing 52

Microdosing Research and Development Sleep Chronic Pain 52

Veriheal

NOVEMBER 17, 2020

According to the Ohio State Medical Marijuana website, the petition will not be considered if received after December 31, 2020, if it seeks to add a broad category of diseases or conditions, or if the condition is one that has been previously reviewed by the board and rejected unless new scientific research that supports the request is offered.

Conditions 98

Conditions Research and Development Pharmaceutical Clinical Trials 98

Project CBD

FEBRUARY 28, 2023

This was somewhat less than the nearly 37% decline seen in 2020. decline from 2020. 13 Although many review authors reported inconclusive findings due to low-quality studies, they noted that evidence from human clinical trials seems to support CBD’s positive effects on nociceptive pain (i.e., million on these products.

CBD 144

CBD Seed-To-Sale Food Access 144

CannaMD

NOVEMBER 15, 2020

research on marijuana harms – such as cannabis withdrawal, treatments for substance abuse and use/exposure during pregnancy or infancy – received 20 times more funding than research on cannabis therapeutics. While some funds are being used to study cannabis medical treatments, the majority of funding is still used to research harms.

DEA 105

DEA Clinical Trials Cannabinoids Treatment 105

LifeCannMD

MAY 27, 2025

Every medication, every treatment, every specialist they could find. CBD acts like anti-rust treatment for your brain. We’ll talk about your history, current treatments, and how cannabis might help. Charlotte’s Legacy Lives On Charlotte Figi passed away in 2020, but her impact on medicine continues every single day.

CBD 52

CBD Oil Epilepsy Sleep 52

Cannabis Law Report

FEBRUARY 24, 2022

Subsection 56(1) of the CDSA will exempt medical providers from enforcement of the CDSA when providing psilocybin and MDMA treatment to patients suffering serious or terminal health conditions. Physicians still need SAP approval on a patient-by-patient basis and SAP approval is only granted when other available treatments prove ineffective.

Therapy 52

Therapy Access Clinical Trials Treatment 52

Cannabis Law Report

SEPTEMBER 9, 2021

Medical cannabis is used for the treatment of various chronic conditions, such as Parkinson’s disease, Alzheimer’s disease, arthritis, cancer, depression, anxiety, epilepsy, and other neurological conditions. Thus, a wide application scope has led to an increased product demand for the treatment of various chronic conditions.

Recreational 73

Recreational Hemp THC Legalization 73

Cannabis Law Report

AUGUST 25, 2021

“Lucid has successfully developed a strong pipeline of novel therapeutic compounds — supported by IP in order to advance to future clinical trials — and we are confident that the experience the Lucid leadership team brings will allow us to immediately start the process towards clinical trials to further advance these promising therapies.

Clinical Trials 85

Clinical Trials Research and Development Therapy Conditions 85

Cannabis Law Report

DECEMBER 23, 2021

However, no single cannabinoid drug has received widespread approval in the treatment of pain. The use of cannabinoids in the treatment of medical conditions offers major opportunities, but also challenges to anyone operating in the space. The current medical cannabis market is bursting with innovation.

Pharmaceutical 74

Pharmaceutical Clinical Trials Research and Development Cannabinoids 74

LifeCannMD

AUGUST 2, 2024

Medical Marijuana is increasingly being considered as a potential treatment for severe migraines. More clinical trials are needed to establish definitive efficacy and safety profiles. – Details: The research emphasized the need for controlled clinical trials to better understand the optimal dosages and strains.

Clinical Trials 52

Clinical Trials Marijuana Research and Development Cannabinoids 52

Cannabis Law Report

JANUARY 27, 2022

The distribution of clinical trials across Phase I-IV indicates that the majority of trials for FXS have been in the early and midphases of development, with 77% of trials in Phase I-II, and only 23% in Phase III-IV. The US has a substantial lead in the number of FXS clinical trials globally. KEY TAKEAWAYS.

Clinical Trials 40

Clinical Trials Therapy Cannabinoids Topical 40

CannaMD

AUGUST 26, 2020

Current Cocaine Treatments. As researchers point out: There is no gold standard pharmacological treatment for dependence on cocaine. Although several drugs have been investigated, there is no strong or consistent evidence indicating any of these drugs for the treatment of cocaine use disorder. mice/rats). But not to worry.

Therapy 98

Therapy CBD Research and Development Treatment 98

Cannabis Law Report

OCTOBER 13, 2021

The PCT filing also includes support for future research programs respecting various systems which seek to minimize negative side effects in psychedelic psychotherapy patients, methods that enable lower and sub-psychedelic doses without impacting treatment efficacy and increasing the long-term efficacy of psychedelic sessions. About Cybin.

Clinical Trials 52

Clinical Trials Research and Development Treatment Conditions 52

SpeedWeed

MARCH 28, 2021

CANNABIS CULTURE – The results are now in after the first-ever legal clinical trial into the use of cannabis to treat PTSD, but did the DEA’s rules taint the outcome? Seventy-six mostly male veterans between the ages of 24 and 77 completed the Phase 1 trial. View original article.

Clinical Trials 52

Clinical Trials DEA Treatment THC 52

SpeedWeed

JULY 23, 2021

When you’re talking about wanting to do an actual clinical trial, you need a diversity of people that participate and one state just does not have the diversity of people that are required,” Towle said. It means] better research, and then that research will lead to better treatments with fewer side effects,” said Towle.

Clinical Trials 52

Clinical Trials Research and Development DEA Cannabinoids 52

Cannabis Law Report

MAY 10, 2022

Anxiety and sleep disorders were some reasons given for prescriptions despite lack of evidence for cannabis treatment, researchers find. The data also shows that prior to 2020, people between 45 and 52 years old had the highest incidence of prescriptions. We are aware of clinical trials in that space, but not strong evidence.”.

Medicine 52

Medicine Clinical Trials Data Sleep 52

TheAnswerPage

FEBRUARY 3, 2020

Is the US VA Office of research and Development conducting any clinical trials that evaluate the use of CBD for the treatment of PTSD? The trial will compare PE + CBD to PE + placebo in a sample of 136 military Veterans with PTSD at the VA San Diego Medical Center. See Answer. See Answer.

Clinical Trials 40

Clinical Trials Research and Development Therapy Treatment 40